jueves, 8 de julio de 2010

Have you heard?

Have you heard?

The Lancet's Impact Factor has recently gone up to 30.76 - just one more reason why you should read the independent and authoritative voice in global medicine.
More essential reading from The Lancet

- Most read articles in 2010
- Sign up for ETOCs
- Plus Video and Audio content
Need more reasons why you should read The Lancet?

• The journal is currently ranked second in the general medicine category (ISI Journal Citation Reports, 2009), which makes it one of the world's leading medical journals.

The Lancet remains independent without affiliation to a medical or scientific organization, ensuring our coverage is truly impartial.

• Gain a professional edge by receiving the highest standard and most clinically relevant articles published across the full breadth of global medicine.

• All articles are stringently peer-reviewed and edited for scientific and clinical relevance. Many of the articles published in The Lancet are practice changing and policy changing.

• Fast-Tracked articles are published first online and live on thelancet.com before the print issue, reaching over 1.9 million registered users

• Fast-Tracked articles are published within 4 weeks of submission, bringing you ground-breaking research when you need it most

• Dig deeper into key global issues by listening to The Lancet Podcast featuring editorial staff and interviews with the study authors of key papers

Since 1823 our mission has been to publish the best medical science in the world with a zeal to counter the forces that undermine the values of medicine, be they political, social, or commercial. We seek to publish high-quality clinical trials that will alter medical practice, and our commitment to international health ensures that research and analysis from all regions of the world is widely covered.

Stay informed with the independent and authoritative voice in global medicine. For more information visit: www.thelancet.com
Most read articles via TheLancet.com*

Below are the Top 10 most read articles from The Lancet in 2010 to date.

1. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5

2. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial

3. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension

4. Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis

5. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

6. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

7. Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970-2010: a systematic analysis of progress towards Millennium Development Goal 4

8. Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension

9. Group cognitive behavioural treatment for low-back pain in primary care: a randomised controlled trial and cost-effectiveness analysis

10. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study

* In 2010. Articles are available to purchase individually or can be accessed via a full Online Only subscription with a 25% discount available until 30 July.
Click here to subscribe

Get full access to The Lancet via an Online Only 'paper free' subscription.
Until 30 July 2010 you can subscribe at only 75% of the normal price.

- High-quality research, challenging editorial and a global outlook.

- Access all articles dating back
to 1996

- 14 years of content and pay for only 39 issues.

To subscribe, click here


All content published by The Lancet journals - in your specialty.

Each of our 15 Specialty Collections is fully searchable, and clustered into topics to make it even quicker to find the article you want. 

Pay only for the collection, topics and articles you need.

For more information click here.


You are receiving this email because you are a registered user on TheLancet.com and opted in to receive related information from TheLancet.com. This email has been sent from The Lancet, Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford, OX5 1GB, registered in England with registered number 1982084.

To update your profile, click here, log in with your username and password, and amend your preferences. If you are unable to remember your log-in details, you can unsubscribe by clicking here.

Forgotten your password? 
Click here - for a reminder.

Copyright © 2010 Elsevier Limited. All rights reserved. Please read our site's 
Privacy Policy.

THE LANCET ® is a registered trademark of Elsevier Properties SA, used under license.

No hay comentarios:

Publicar un comentario